top of page
Warren Hoeffler in Color (2).jpeg

Warren K. Hoeffler Ph.D, CEO

Warren is the founder of HOF Therapeutics and our Chief Executive Officer. Previously, he was the Chief Exective Officer for Xgene Corporation, a company that conducted contract work for larger companies and received a Small Business Grant from the NIH. He pursued an independent line of experimentation over multiple years to test key scientific concepts to unlock barriers to development of tissue and organ production from cultured cells, while also uncovering additional technical breakthroughs. In addition to his business career, he taught at Dominican University in their joint graduate program in biology with The Buck Research Institute for Aging, and in the Nursing and Science Programs. Prior to this he was an appointed faculty in the Dermatology Department at the Stanford University School of Medicine, and was on the Scientific Advisory Board of Geron Corporation. He has numerous scientific publications, including in Cell, Nature, Journal of Experimental Medicine, Journal of Biological Chemistry, and Journal of Investigative Dermatology. He has filed and has been granted multiple U.S. and foreign patents.


Alex Lancaster Business Development 

Alex Lancaster Marketing Manager is a graduate of Clemson University with a Business Degree. He has years of experience with direct sales, and was trained as an intern in Dr. Hoeffler’s laboratory doing cell culture. He is the first contact to connect our customers with our goods and services. He says" I am thrilled to have this opportunity to introduce new customers to our CAP Organ technology, our new way to make complex human organ components. It is actually easy to explain our business advantage. HOF Therapeutics knows how to trigger cells to assemble into the fundamental human organ components as seen in our microscope sections, which contain more fine structures. Other labs are spending bigger government budgets on analysis of otherwise more primitive models.” 


Monica Steward Director of Marketing and Communications

Monica comes to HOF Therapeutics with over twenty years experience in sales and marketing.  Having previously worked in the marketing and sales of an educational software platform throughout the United States and Canada with Your Translation Company, Monica feels HOF Therapeutics is the perfect opportunity to blend sales with an ongoing pursuit and avid interest in the fields of Computer Science and the Biological Sciences.  Monica brings years of experience and enthusiasm in doing business with international clients throughout Asia, Europe, South America and the Middle East.

Screen Shot 2022-07-21 at 2.47.21 PM.png

Elias Husary 

Elias currently serves on the board of HOF Therapeutics. Chief Executive Officer and President, and co-owner of Nine Eighteen Medical Inc. in Petaluma, California from March 2010 - present. Previous CEO and President of Newmatic Medical from January 2001 - November 2009. Elias brings a practical balance of real-world business experience with a motivation to improve the patient experience and medical outcomes. He is a graduate of the University of California, Santa Barbara, and the previous president of the Rotary Club of Petaluma.

Screen Shot 2022-07-25 at 9.26.45 PM.png

Kai McFarland

Kai currently serves on the board of HOF Therapeutics. As an Analyst and Chief Compliance Officer for SEC regulations at Clearlake Advisors and a Chartered Financial Analyst (CFA), Kai has 10+ years of investing experience with private equity and hedge funds. A highly detailed analyst and researcher with a deep commitment to excellence and integrity in all endeavors, he brings his experience in operational finance and investment to HOF. He is a graduate of Lehigh University with a Bachelor of Science and Finance, Engineering Minor. 

bottom of page